Navigation Links
Pittsburgh-based BIOSAFE Receives EPA Registration and Enters Into Commercialization Agreement with Union Springs Pharmaceuticals

PITTSBURGH, Dec. 14, 2010 /PRNewswire/ -- BIOSAFE, Inc. has announced that it has registered with the USEPA two new water-based antimicrobial solutions and entered into a commercialization agreement with Kentucky-based Union Springs Pharmaceuticals to market products containing BIOSAFE's patented and exclusive antimicrobial polymer, HM4100.  The unique and effective antimicrobial technology safely protects surfaces from harmful and degrading effects of bacteria, mold, mildew and fungi.  HM4100 is approved for uses in a variety of substrates, including textiles, plastics, medical goods, construction and building products, and consumer products.  This agreement gives Pittsburgh-based BIOSAFE greater access to the national and international marketplace, beginning with its first large order from Union Springs on December 6, 2010.

Union Springs offers MyClyns® (antimicrobial germ spray) and will offer products containing HM4100 under the MyClyns Antimicrobial Surface Treatments banner.  HM4100 is a residual long-term antimicrobial that has proven its effectiveness against the proliferation of such bacteria as MRSA, VREF and Staph, along with mold, mildew and some influenza A viruses that include bird flu (H5N1) and swine flue (H1N1).

Part of the significance of the BIOSAFE solution is that it can be applied to both hard and porous surfaces, from tables, desks and counters, to bedding, clothing and carpeting.

"This agreement with Union Springs Pharmaceuticals and the launch of MyClyns products featuring our patented HM4100 antimicrobial is more than just a business venture," said Max Fedor, CEO of BIOSAFE.  "The health protection benefits for millions of people around the world are potentially very significant.  Thanks to this strategic alliance with Union Springs Pharmaceuticals, we will be able to build a strong market presence around our unique technology."

Union Springs Pharmaceuticals plans to immediately market five new products containing HM4100, incorporating the antimicrobial treatment in sprays, surface wipes, fabric refreshers and as a laundry additive.  Each of the new products will be launched in the first quarter of 2011. Following these steps, Union Springs plans to market additional products treated with HM4100.

"BIOSAFE continues to explore ways for further enhance the commercialization pipeline for HM4100," said Mr. Fedor.  "The antimicrobial now has been approved by the United States EPA in both powder and liquid form, which improves scalability and distribution.  To achieve this vision, BIOSAFE will work to form new strategic partnerships to grow into new geographic and vertical industry markets."


Pittsburgh-based BIOSAFE, Inc. has been funded by the Pittsburgh Life Sciences Greenhouse, Innovation Works, and Bluetree Allied Angels, manufactures and sells an antimicrobial polymer, HM 4100.  HM4100 is effective in defending against bacteria, fungi (mold and mildew), yeast, algae, and even certain viruses.  BIOSAFE's patented technology is an excellent antimicrobial additive for treating plastics, textiles, metals, ceramics, and activated carbon, with superior performance and economic benefits.  For further information, visit the BIOSAFE website ate

About Union Springs Pharmaceuticals

Union Springs Pharmaceuticals specializes in providing innovative personal and environmental protection products for the EMS, fire, law enforcement, corrections, military, government, healthcare and consumer markets.  Union Springs Pharmaceuticals currently markets MyClyns, the revolutionary germ protection spray that is safe to spray into the eyes, nose and mouth.  The company also offers the T-5000 Series P-95 respirators and ViralClyns N95 respirators, which are the only disposable respirators with an infused EPA-approved antimicrobial for extra protection, and ExtendaClyns, a non-alcohol based hand sanitizer, that kills 99.9 percent of germs that doesn't dry out hands and skin, and offers long-lasting effect.  More information on Union Springs Pharmaceuticals and its products can be found at

Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Medicsight Receives Brazilian State Food and Drug Administration Approval for ColonCAD Software
2. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
3. SGX - Lilly Merger Offer Receives Positive Opinions From Proxy Advisory Firms
4. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
5. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
6. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
7. Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents
8. Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program
9. Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores
10. TorreyPines Therapeutics Receives NASDAQ Deficiency Notice
11. Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
Post Your Comments:
(Date:11/26/2015)... MUMBAI , November 26, 2015 ... --> Accutest Research ... accredited Contract Research Organization (CRO), has ... Chase Cancer Center - Temple Health ... ,     (Photo: ) ...
(Date:11/25/2015)... --> ... 2020 report analyzes that automating biobanking workflow will ... long-term samples, minimizing manual errors, improving the workflow ... errors such as mislabeling or inaccurate sample barcoding ... a vital role in blood fractionation, DNA extraction, ...
(Date:11/25/2015)... 25, 2015 2 nouvelles études permettent ... les différences entre les souches bactériennes retrouvées dans la ... des êtres humains . Ces recherches  ouvrent une nouvelle ... prise en charge efficace de l,un des problèmes ... chats .    --> 2 nouvelles études ...
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 /PRNewswire/ ... ), a biotechnology company developing bioengineered organ implants for ... will present at the LD Micro "Main Event" ... p.m. PT. The presentation will be webcast live and ... will also be available at the conference for one-on-one ...
Breaking Biology Technology:
(Date:11/9/2015)...  Synaptics Inc. (NASDAQ: SYNA ), the leading ... into the automotive market with a comprehensive and dedicated ... consumer electronics human interface innovation. Synaptics, industry-leading touch controllers, ... automotive industry and will be implemented in numerous locations ... , Japan , and ...
(Date:10/29/2015)... Oct. 29, 2015  The J. Craig Venter Institute ... "DNA Synthesis and Biosecurity: Lessons Learned and Options for ... Health and Human Services guidance for synthetic biology providers ... --> --> Synthetic ... the potential to pose unique biosecurity threats. It now ...
(Date:10/29/2015)... NXTD ) ("NXT-ID" or ... the growing mobile commerce market and creator of ... leading marketplace to discover and buy innovative technology ... on StackSocial for this holiday season.   ... a biometric authentication company focused on the growing ...
Breaking Biology News(10 mins):